Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,641 GBX | +0.29% | +3.69% | +13.23% |
05:10pm | Moody’s Affirms Haleon’s Ratings on Strong Operating Performance | MT |
Apr. 24 | CureVac Begins Early Stage Portion of Investigational Vaccine Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.23% | 83.1B | |
+24.17% | 562B | |
-6.35% | 358B | |
+18.67% | 322B | |
+7.53% | 297B | |
+13.55% | 219B | |
+6.06% | 199B | |
-10.35% | 196B | |
-11.20% | 149B | |
-6.87% | 146B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GlaxoSmithKline : Morgan Stanley Raises GlaxoSmithKline PT, Keeps Equal-Weight Rating